David Smadja to Endothelial Cells
This is a "connection" page, showing publications David Smadja has written about Endothelial Cells.
Connection Strength
1.325
-
Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity. Angiogenesis. 2019 05; 22(2):325-339.
Score: 0.352
-
Forearm ischemia decreases endothelial colony-forming cell angiogenic potential. Cytotherapy. 2014 Feb; 16(2):213-24.
Score: 0.247
-
Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening. PLoS One. 2013; 8(6):e65114.
Score: 0.240
-
[Characterization of endothelial progenitor cells and putative strategies to improve their expansion]. J Soc Biol. 2009; 203(2):197-207.
Score: 0.182
-
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis. 2021 11; 24(4):755-788.
Score: 0.105
-
Curative anticoagulation prevents endothelial lesion in COVID-19 patients. J Thromb Haemost. 2020 09; 18(9):2391-2399.
Score: 0.098
-
Human endoglin as a potential new partner involved in platelet-endothelium interactions. Cell Mol Life Sci. 2018 04; 75(7):1269-1284.
Score: 0.081
-
Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia. Expert Opin Ther Targets. 2017 10; 21(10):933-947.
Score: 0.020